Given their role in modulating cancer cell behavior, GABA receptors represent potential therapeutic targets. GABA agonists and antagonists could be explored for their anti-tumor properties. For instance, Baclofen, a GABAB receptor agonist, has shown promise in reducing the proliferation of certain cancer cells in preclinical studies.
